Literature DB >> 24008361

Degradation of cIAPs contributes to hepatocyte lipoapoptosis.

Yuko Akazawa1, Maria Eugenia Guicciardi, Sophie C Cazanave, Steven F Bronk, Nathan W Werneburg, Keisuke Kakisaka, Kazuhiko Nakao, Gregory J Gores.   

Abstract

Hepatocyte apoptosis is a hallmark of nonalcoholic steatohepatitis. We have previously observed that the saturated free fatty acids (FFAs) induce hepatocyte apoptosis in part via a death receptor 5 (DR5)-mediated signaling pathway. Cellular inhibitor of apoptosis protein 1 and 2 (cIAP-1 and cIAP-2) proteins are potent inhibitors of death receptor-mediated apoptosis. However, the role of the cIAPs in FFA-mediated hepatocyte apoptosis is unexplored. Our aim was to determine whether cIAPs are dysregulated during hepatocyte lipoapoptosis. cIAP proteins underwent rapid cellular elimination following treatment with the saturated FFAs palmitate (PA) and stearate. In contrast, PA did not decrease cIAP-1 and cIAP-2 mRNA expression in the cells. Degradation of cIAPs was dependent on their E3-ligase activity, suggesting that cIAPs undergo autoubiquitination that leads to proteasomal degradation. Huh-7 cells stably expressing shRNA targeting cIAP-1, but not cIAP-2, displayed enhanced sensitivity to PA-mediated apoptosis. Incubation with the SMAC mimetic JP1584, which induces rapid degradation of cIAPs, also enhanced PA-mediated apoptosis. Hepatocytes isolated from DR5 knockout mice exhibited reduced apoptosis following treatment with PA plus JP1584, implying that degradation of cIAPs sensitizes to DR5-mediated cell death pathways. A decrease of cIAP-1 was also observed in tissue from patients with nonalcoholic steatohepatitis compared with normal obese subjects. Collectively, these results implicate proteasomal degradation of cIAPs by FFA as a mechanism contributing to hepatocyte lipoapoptosis.

Entities:  

Keywords:  DR5; IAPs; SMAC mimetics; apoptosis; free fatty acids

Mesh:

Substances:

Year:  2013        PMID: 24008361      PMCID: PMC3840239          DOI: 10.1152/ajpgi.00111.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  34 in total

1.  DR5 knockout mice are compromised in radiation-induced apoptosis.

Authors:  Niklas Finnberg; Joshua J Gruber; Peiwen Fei; Dorothea Rudolph; Anka Bric; Seok-Hyun Kim; Timothy F Burns; Hope Ajuha; Robert Page; Gen Sheng Wu; Youhai Chen; W Gillies McKenna; Eric Bernhard; Scott Lowe; Tak Mak; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

2.  Cellular inhibitor of apoptosis protein-1 (cIAP1) plays a critical role in β-cell survival under endoplasmic reticulum stress: promoting ubiquitination and degradation of C/EBP homologous protein (CHOP).

Authors:  Yanfei Qi; Pu Xia
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

3.  c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment.

Authors:  R J Clem; T T Sheu; B W Richter; W W He; N A Thornberry; C S Duckett; J M Hardwick
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

4.  Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

Authors:  G S Wu; T F Burns; Y Zhan; E S Alnemri; W S El-Deiry
Journal:  Cancer Res       Date:  1999-06-15       Impact factor: 12.701

Review 5.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

6.  Smac/Diablo antagonizes ubiquitin ligase activity of inhibitor of apoptosis proteins.

Authors:  Emma M Creagh; Brona M Murphy; Patrick J Duriez; Colin S Duckett; Seamus J Martin
Journal:  J Biol Chem       Date:  2004-04-12       Impact factor: 5.157

7.  Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.

Authors:  Yuko Akazawa; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Alisan Kahraman; Maria Eugenia Guicciardi; Xue Wei Meng; Shigeru Kohno; Vijay H Shah; Scott H Kaufmann; Mark A McNiven; Gregory J Gores
Journal:  Gastroenterology       Date:  2009-03-09       Impact factor: 22.682

8.  IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

Authors:  James E Vince; W Wei-Lynn Wong; Nufail Khan; Rebecca Feltham; Diep Chau; Afsar U Ahmed; Christopher A Benetatos; Srinivas K Chunduru; Stephen M Condon; Mark McKinlay; Robert Brink; Martin Leverkus; Vinay Tergaonkar; Pascal Schneider; Bernard A Callus; Frank Koentgen; David L Vaux; John Silke
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

Review 9.  IAPs: guardians of RIPK1.

Authors:  M Darding; P Meier
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

10.  Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.

Authors:  M Darding; R Feltham; T Tenev; K Bianchi; C Benetatos; J Silke; P Meier
Journal:  Cell Death Differ       Date:  2011-02-18       Impact factor: 15.828

View more
  9 in total

1.  Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study.

Authors:  John F DiPersio; Harry P Erba; Richard A Larson; Selina M Luger; Martin S Tallman; Jeffrey M Brill; Gregoire Vuagniaux; Elisabeth Rouits; J Mel Sorensen; Claudio Zanna
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-03-05

2.  Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study.

Authors:  Herbert I Hurwitz; David C Smith; Henry C Pitot; Jeffrey M Brill; Rashmi Chugh; Elisabeth Rouits; Joseph Rubin; John Strickler; Gregoire Vuagniaux; J Mel Sorensen; Claudio Zanna
Journal:  Cancer Chemother Pharmacol       Date:  2015-02-27       Impact factor: 3.333

3.  Growth Hormone Mediates Its Protective Effect in Hepatic Apoptosis through Hnf6.

Authors:  Kewei Wang; Minhua Wang; Maureen Gannon; AiXuan Holterman
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

4.  FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis.

Authors:  Sathish Kumar Natarajan; Bailey A Stringham; Ashley M Mohr; Cody J Wehrkamp; Sizhao Lu; Mary Anne Phillippi; Dee Harrison-Findik; Justin L Mott
Journal:  J Lipid Res       Date:  2017-03-01       Impact factor: 5.922

5.  Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis.

Authors:  Hiroko Takaki; Yuko Akazawa; Youko Kido; Mami Morishita; Takuya Honda; Hidetaka Shibata; Satoshi Miuma; Hisamitsu Miyaaki; Naota Taura; Hisayoshi Kondo; Kazuhiko Nakao
Journal:  Med Sci Monit       Date:  2017-09-21

Review 6.  To die or not to die: death signaling in nonalcoholic fatty liver disease.

Authors:  Yuko Akazawa; Kazuhiko Nakao
Journal:  J Gastroenterol       Date:  2018-03-24       Impact factor: 7.527

Review 7.  Pathogenesis of Nonalcoholic Steatohepatitis: An Overview.

Authors:  Gopanandan Parthasarathy; Xavier Revelo; Harmeet Malhi
Journal:  Hepatol Commun       Date:  2020-01-14

Review 8.  Targeting neddylation E2s: a novel therapeutic strategy in cancer.

Authors:  Yi-Chao Zheng; Yan-Jia Guo; Bo Wang; Chong Wang; M A A Mamun; Ya Gao; Hong-Min Liu
Journal:  J Hematol Oncol       Date:  2021-04-07       Impact factor: 17.388

Review 9.  Apoptosis and non-alcoholic fatty liver diseases.

Authors:  Tatsuo Kanda; Shunichi Matsuoka; Motomi Yamazaki; Toshikatsu Shibata; Kazushige Nirei; Hiroshi Takahashi; Tomohiro Kaneko; Mariko Fujisawa; Teruhisa Higuchi; Hitomi Nakamura; Naoki Matsumoto; Hiroaki Yamagami; Masahiro Ogawa; Hiroo Imazu; Kazumichi Kuroda; Mitsuhiko Moriyama
Journal:  World J Gastroenterol       Date:  2018-07-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.